Business information > Business articles > Magazines > Business magazines > Wall Street Transcript Digest > June 2005

ROUNDTABLE FORUM: INVESTING IN SMALL CAP BIOTECHNOLOGY.

Article from: Wall Street Transcript Digest | June 27, 2005 | Copyright

(ZAF400) ROUNDTABLE FORUM: INVESTING IN SMALL CAP BIOTECHNOLOGY. In one of TWST's hallmark roundtable discussions, a distinguished panel of analysts reviews at great length the performance of the industry, and examines the factors that determine the success of companies within the sector. It discusses changes within the sector, and especially as they relate to competition, globalization, cost and price pressures and mergers and alliances between companies. Based on its analysis of the industry, the panel identifies companies best …

Read all of this article – and millions more – with a FREE, 7-day trial!

Related newspaper, magazine, and journal articles

Investors' ultimatum: Wall Street wants to know everything: to cultivate investors' trust, lifescience companies must better communicate their financial data. (Communication).
Pharmaceutical Executive; November 1, 2002; 700+ words

...investment stories with Wall Street's new standards...science companies and Wall Street and provides specific...months, the S&P Small Cap Biotechnology and Pharmaceutical...Failure to Communicate Wall Street's frustration in...

Investors' ultimatum
Pharmaceutical Executive; November 1, 2002; 700+ words

Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of Directors.
Biotech Week; September 2, 2009; 590 words

...associated with during my Wall Street career." Ms. Chovav...original coverage of large cap biotechnology companies such as AMGEN...science sector as a Wall Street equity research analyst...been recognized by The Wall Street Journal as the best...

DJ. WSJ.COM:European Stocks Extend Decline In Afternoon Trade.
FWN Select; August 12, 2002; 700+ words

Aug 12, 2002 A WALL STREET JOURNAL ONLINE News...afternoon trading Monday as Wall Street opened weaker. The...contraction. Shares in mid-cap biotechnology company Powderject lost...updated news from The Wall Street Journal, see WSJ...

DJ. US Stocks Move Higher Despite Weak Durable Goods Report.
FWN Select; May 28, 2003; 700+ words

...of 22 cents a share, beating Wall Street's target by 2 cents, saying...90 cents a share, ahead of a Wall Street estimate of 88 cents. Costco...to 209.85. Two small-cap biotechnology companies with news on anthrax...

Big is beautiful: Large biotech firms are in fashion. Small ones are more unpopular than ever.(Brief Article)
The Economist (US); March 27, 1999; 700+ words

...better than their larger rivals. In the unnatural world of Wall Street, however, such rules do not always apply. American biotechnology...a little longer, is no longer directed towards small-cap biotechnology firms. According to Bill Slattery, a biotechnology analyst...

DJ. US Stocks Choppy Despite Strong Factory Orders Report.
FWN Select; September 4, 2003; 700+ words

...up from an initial estimate of 5.7%, and higher than Wall Street's estimate of 6.3%. The Dow Jones Industrial Average...Index up 0.46, or 0.2%, to 249.33. Two small-cap biotechnology issues are soaring. VaxGen has surged 1.48, or 32...

Vernon T. Bernardino Joins Dawson James Securities, Inc. as Senior Research Analyst.
Biotech Week; April 28, 2010; 700+ words

...served as an equity analyst at UBS covering small and large cap biotechnology companies; and as a healthcare industry analyst at Sturdivant...ranked biologics drug pipeline in the industry. Prior to Wall Street, Mr. Bernardino also served as Vice President of Business...

Search HighBeam Business for more related articles

About us Contact us Terms and conditions Privacy policy

Arrive Prepared – our blog about business news and market research.